PCSK9 levels in the five patients with PSC, as well as in the six patients with PBC who experienced decompensation during the course of the disease, were similar to those in patients who did not experience this adverse event (Fig. 5a, b). Here, PCSK9 is linked to pancreatic serous cystadenoma.